Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.
作者信息
Duke Brian OL
机构信息
River Blindness Foundation, 2 Hillside, Lancaster, LA1 1YH, United Kingdom.
出版信息
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S1. doi: 10.1186/1475-2883-2-S1-S1.
Abstract
摘要
相似文献
1
Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.概述：关于在罗阿丝虫病流行地区使用美迪善（Mectizan）治疗盘尾丝虫病后严重不良事件的科学工作组报告。
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S1. doi: 10.1186/1475-2883-2-S1-S1.
2
Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.在罗阿丝虫病流行地区使用美迪善（Mectizan®）治疗盘尾丝虫病后严重不良事件科学工作组报告
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S2. doi: 10.1186/1475-2883-2-S1-S2.
3
Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.低度流行盘尾丝虫病热点地区：通过微观绘图和环境划定确定高风险区域
Infect Dis Poverty. 2015 Aug 16;4:36. doi: 10.1186/s40249-015-0069-6. eCollection 2015.
4
A Framework for Decision-Making for Mass Distribution of Mectizan(R) in Areas Endemic for Loa loa.在罗阿丝虫病流行地区大规模分发美迪善（Mectizan®）的决策框架
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S9. doi: 10.1186/1475-2883-2-S1-S9.
5
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.罗阿丝虫病流行地区盘尾丝虫病的检测而非治疗策略。
N Engl J Med. 2017 Nov 23;377(21):2044-2052. doi: 10.1056/NEJMoa1705026. Epub 2017 Nov 8.
6
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.在盘尾丝虫病和罗阿丝虫病共同流行地区，与伊维菌素治疗后严重不良事件相关的规划和沟通问题
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S10. doi: 10.1186/1475-2883-2-S1-S10.
7
Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study.喀麦隆南部罗阿丝虫寄生虫的遗传异质性：一项初步研究。
Filaria J. 2004 Jun 29;3(1):4. doi: 10.1186/1475-2883-3-4.
8
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.在罗阿丝虫感染流行地区用伊维菌素大规模治疗盘尾丝虫病后的严重反应。
Lancet. 1997 Jul 5;350(9070):18-22. doi: 10.1016/S0140-6736(96)11094-1.
9
Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis.盘尾丝虫病治疗中严重不良事件的临床表现及结果
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S6. doi: 10.1186/1475-2883-2-S1-S6.
10
Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future.1989年至2001年盘尾丝虫病群体治疗项目报告的与伊维菌素给药时间相关的罗阿罗阿脑病：对未来的启示
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S7. doi: 10.1186/1475-2883-2-S1-S7.
引用本文的文献
1
Impact of repeated mass ivermectin administration using a community directed approach on . infection in of the rain forest and forest savanna of Cameroon.采用社区指导方法重复大规模使用伊维菌素对喀麦隆雨林和森林稀树草原地区感染的影响。
Parasite Epidemiol Control. 2024 Feb 17;25:e00343. doi: 10.1016/j.parepi.2024.e00343. eCollection 2024 May.
2
Central and Peripheral Nervous System Disorders Following Ivermectin Mass Administration: A Descriptive Study Based on the Democratic Republic of Congo Pharmacovigilance System.伊维菌素大规模给药后中枢和外周神经系统疾病：基于刚果民主共和国药物警戒系统的描述性研究
Drugs Real World Outcomes. 2017 Sep;4(3):151-158. doi: 10.1007/s40801-017-0110-0.
3
Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control.绘制喀麦隆罗阿丝虫的分布情况，以支持非洲盘尾丝虫病控制计划。
Filaria J. 2004 Aug 6;3(1):7. doi: 10.1186/1475-2883-3-7.
4
Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study.喀麦隆南部罗阿丝虫寄生虫的遗传异质性：一项初步研究。
Filaria J. 2004 Jun 29;3(1):4. doi: 10.1186/1475-2883-3-4.
本文引用的文献
1
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.在盘尾丝虫病和罗阿丝虫病共同流行地区，与伊维菌素治疗后严重不良事件相关的规划和沟通问题
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S10. doi: 10.1186/1475-2883-2-S1-S10.
2
A Framework for Decision-Making for Mass Distribution of Mectizan(R) in Areas Endemic for Loa loa.在罗阿丝虫病流行地区大规模分发美迪善（Mectizan®）的决策框架
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S9. doi: 10.1186/1475-2883-2-S1-S9.
3
Ivermectin: does P-glycoprotein play a role in neurotoxicity?伊维菌素：P-糖蛋白在神经毒性中起作用吗？
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S8. doi: 10.1186/1475-2883-2-S1-S8.
4
Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future.1989年至2001年盘尾丝虫病群体治疗项目报告的与伊维菌素给药时间相关的罗阿罗阿脑病：对未来的启示
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S7. doi: 10.1186/1475-2883-2-S1-S7.
5
Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.给盘尾丝虫病患者服用伊维菌素后出现不良临床事件的可能致病途径。
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S5. doi: 10.1186/1475-2883-2-S1-S5.
6
Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.喀麦隆大规模伊维菌素治疗盘尾丝虫病相关罗阿丝虫严重不良事件的临床表现、流行病学及结局
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S4. doi: 10.1186/1475-2883-2-S1-S4.
7
Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.用伊维菌素治疗盘尾丝虫病以控制病情后的严重不良事件：报告病例综述
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S3. doi: 10.1186/1475-2883-2-S1-S3.
8
STUDIES ON LOIASIS IN MONKEYS. IV. EXPERIMENTAL HYBRIDIZATION OF THE HUMAN AND SIMIAN STRAINS OF LOA.
Ann Trop Med Parasitol. 1964 Dec;58:390-408.
9
10
Studies on loiasis in monkeys. III. The pathology of the spleen in drills (Mandrillus leucophaeus) infected with Loa.
Ann Trop Med Parasitol. 1960 Jun;54:141-6.
Zotero 插件